Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Nailbiter2on Jun 26, 2024 8:45pm
239 Views
Post# 36108138

This is what I think happened

This is what I think happenedWe were told that we didn't have the funds to pay our auditors to file Q4-23.
I think that's BS.
 
Rory Mc Duck could have floated us for a few more freebie shares
and that didn't happen.
 
Here's what I figured happened. I could be all green behind the ears
and where I stash my coin but this is what I figure.
 
Q4 came in and it sucked.
Instead of causing the kind of panic that happens when somebody
shows up at a club with an aykay, we decided not to file.
 
The numbers were not there because the healthcare partners were not there.
 
Q1-24 was filed and it was ugly which tells me Q4 must have sucked huge
Soweto seedless lemons.
 
Q4 would have knocked us down to two cents and Q1 would have been 
the pile-driver to oblivion.
 
So we just ceased trading until one plus one finally equals three.
Nobody in, nobody out... Just steam and chill, whether that's legal or not.
It's just what has been going through my head.
 
July is around the corner. I have found out that ..
 
If we miss the date, the Failure to File Cease Trade Order can change to a Cease Trade Order and would require the company to reapply for trading on the exchange. 
It would be more costly and time consuming.
FFCTO's have a 90 day period in which once the financials are filed trading automatically resumes.
 
July, we find out for sure.
In May, I sent James a real nasty and he actually replied saying,
 
 If this quarter returns to normal or shows growth, it will bear it out.
I imagine you will then call with an immediate apology. Yes?
 
Well James, my apology is sitting on a shelf all buffed and shiny, ready to deliver.
 
Show me you are made of what it takes otherwise you and my apology can take a soak in the River Feugh.
 
Still hopeful but chewing on the last straw.
 
<< Previous
Bullboard Posts
Next >>